This review highlights genetic clinics' role in hereditary cancer management, emphasizing early detection and tailored treatment strategies.
This review article explores the vital role of genetic clinics in the management of hereditary cancers, emphasizing their significance in early detection, tailored treatment, and family screening. It presents analysis of the prevalence of hereditary cancers in India, including breast, ovarian, prostate, colon, and kidney cancers, stressing the necessity for effective genetic testing and counseling services. The manuscript synthesizes available prevalence data, outlines key components and challenges of clinic establishment, and provides strategies for improving public acceptance, access, and workforce capacity. It also focuses on importance of early detection, family screening, and targeted therapies for patients with inherited genetic mutation. In conclusion, the article emphasizes the need for a patient-centered approach, increased access to genetic clinics, exploration of future genomics and technology advancements, and the evaluation of genetic clinics' impact on patient outcomes. By addressing challenges and capitalizing on opportunities, genetic clinics can continue to improve patients' and their families' lives, ultimately contributing to the battle against hereditary cancers.
No takes yet. Share an insight, caveat, or question.
Kapoor et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: